|
MFT-Male match |
MFT-Female match |
|
Transsexuals
(n=53) |
DETECT
(n=149) |
|
Transsexuals
(n=56) |
DETECT
(n=160) |
|
|
mean |
SD |
mean |
SD |
p |
mean |
SD |
mean |
SD |
p |
Age |
49.1 |
10.9 |
46.5 |
9.8 |
0.114 |
48.5 |
11.0 |
45.2 |
10.7 |
0.054 |
Age at diagnosis |
38.6 |
11.7 |
- |
- |
- |
38.6 |
11.7 |
- |
- |
- |
Length of HT |
6.5 |
7.9 |
- |
- |
- |
6.5 |
7.9 |
- |
- |
- |
Diseases |
n |
% |
n |
% |
p |
n |
% |
n |
% |
p |
Cardiovascular |
8 |
15.1 |
68 |
45.6 |
0.000 |
8 |
14.3 |
56 |
35.0 |
0.005 |
Respiratory |
10 |
18.9 |
11 |
7.4 |
0.023 |
10 |
17.9 |
11 |
6.9 |
0.021 |
Neurological |
10 |
18.9 |
21 |
14.1 |
0.410 |
12 |
21.4 |
13 |
8.1 |
0.010 |
Endocrine |
4 |
7.6 |
81 |
54.4 |
0.000 |
4 |
7.1 |
77 |
48.1 |
0.000 |
Gastroenterological |
10 |
18.9 |
33 |
22.2 |
0.618 |
10 |
17.9 |
29 |
18.1 |
0.964 |
Urinary |
5 |
9.4 |
14 |
9.4 |
0.994 |
6 |
10.7 |
21 |
13.1 |
0.640 |
Tumoural |
1 |
1.9 |
5 |
3.4 |
0.595 |
1 |
1.8 |
14 |
8.8 |
0.113 |
Immune-mediated |
6 |
11.3 |
6 |
4.0 |
0.065 |
6 |
10.7 |
6 |
3.8 |
0.061 |
BMI (mean/SD) |
25.2 |
4.7 |
27.8 |
4.4 |
0.000 |
25.2 |
4.7 |
27.0 |
6.1 |
0.027 |
There is no indication of an increased risk associated with hormone treatment in transsexual patients. The values presented are means ± standard deviation (SD) or total
number (n) and percentage (%). Up to 3 controls were matched for each patient. Differences in the number of transsexual patients within the same row of the table are due
to differences in the availability of age-matched control subjects. MFT: male-to-female transsexuals; p: p-value. |